BeStock  
Stocks › Biotechnology › MAZE

Maze Therapeutics MAZE

US equityMarket cap rank #2785Biotechnology
$31.37 −$1.06 (-3.27%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $31.37 0.00%
Open$31.77
Prev close$32.43
Day range$30.88 – $32.80
Volume818.9K
Market cap$1.72B
P/E (TTM)–
Dividend yield–

Analyst view

ConsensusBuy
Analysts9
Average target$61.78+96.9% vs. price
  • Buy 100%
Low $46.00Now $31.37Avg $61.78High $110.00

Recent rating changes

The last 20 actions on file set price targets from $46.00 to $110.00, averaging $70.67.

DateFirmRatingTarget
11 Nov 2026 J.P. Morgan BUY $51.00
10 Nov 2026 CCORF BUY $75.00
10 Nov 2026 Wells Fargo BUY $55.00
10 Nov 2026 H.C. Wainwright BUY $110.00
9 Nov 2026 BTIG BUY $46.00
9 Nov 2026 Citi BUY $50.00
9 Nov 2026 J.P. Morgan BUY –
26 Oct 2026 H.C. Wainwright BUY $110.00
26 Oct 2026 J.P. Morgan BUY –
23 Oct 2026 Citi BUY $50.00
20 Oct 2026 H.C. Wainwright BUY $110.00
19 Oct 2026 CCORF BUY $75.00
15 Oct 2026 Wells Fargo BUY $55.00
5 Oct 2026 H.C. Wainwright BUY $110.00
23 Sep 2026 Wedbush BUY $48.00
23 Sep 2026 Citi BUY $50.00
22 Sep 2026 LifeSci Capital BUY $57.00
22 Sep 2026 BTIG BUY $46.00
22 Sep 2026 Truist Financial BUY $64.00
22 Sep 2026 H.C. Wainwright BUY $110.00

Discussion

No comments yet — be the first to weigh in on MAZE.

Sign in to join the discussion.

Scroll to Top